Dynamic evaluation of MRI-targeted, systematic and combined biopsy for prostate cancer diagnosis through 10 years of practice in a single institution
Lenfant et al., April 2022
Key takeaway:
1) A new prostate biopsy standard has been validated over 10 years in a single academic institution.
2) Evidencing the efficacy of a KOELIS-guided targeted+systematic scheme after positive MRI.
3) In maximizing detection of clinically significant cancer and minimizing unsignificant cancer.
Multicenter Transperineal MRI-TRUS Fusion Guided Outpatient clinic prostate biopsies under local anesthesia
Jacewicz et al., July 2020
Very good detection results (For a PIRADS 4, detection rate of 52% and 70% for csPca and any Pca respectively. For a PIRADS 5, 83.5% and 94% for csPca and any Pca respectively)
Precision matters in MR Imaging-targeted prostate biopsies
Cornud et al., May 2018
This study attests in the real-life setting of the robustness of elastic fusion
registration as MR imaging information (target size and position) was not lost when registered to transrectal US.
Transperineal Targeted Microwave Ablation (TMA) of localized prostate cancer guided by MRI-Ultrasound fusion and organ based tracking: a pilot study
Cornud et al., May 2018
This study attests in the real-life setting of the robustness of elastic fusion
registration as MR imaging information (target size and position) was not lost when registered to transrectal US.
Refining the risk stratification of transrectal biopsy detected prostate cancer by elastic fusion registration transperineal biopsies
Bajeot et al., September 2021
With our system, TP Bx gives efficient results (via elastic & OBT Fusion) in cancer detection and qualification
You can perform TP biopsies under local anesthesia and keep the same accuracy in hitting the target/efficiency in diagnosis. Transperineal biopsies are probably more adapted for anterior targets
Infection rate and complications after 621 transperineal MRI-TRUS fusion biopsies in local anesthesia without standard antibiotic prophylaxis
Gunzel et al., January 2021
KEY TAKE AWAY:
1) MRI-TRUS fusion-guided prostate biopsy led to a significant increase in cancer detection rates
2) TBx under LA are feasible with tolerable pain levels with a low infection rate without antibiotic prophylaxis in a selected patient population
Bringing more accuracy to diagnosis and treatment of prostate cancer
Prostate Cancer is the most common cancer among men, with more than 1.1 million new cases diagnosed every year worldwide, before lung cancer and colorectal cancer.
Managing discordant findings between Multiparametric magnetic resonance imaging and Transrectal magnetic resonance imaging-Directed Prostate Biopsy-The key role of magnetic resonance imaging-Directed Transperineal Biopsy
Bajeaot et al., June 2021
Key results:
1) Very good detection results (For a PIRADS 4, detection rate of 52% and 70% for csPca and any Pca respectively.
2) For a PIRADS 5, 83.5% and 94% for csPca and any Pca respectively)
Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients
Oderda et al. August 2018
Studied elements:
1) The overall and clinically significant cancer detection rate of Koelis fusion biopsies
2) The diagnostic role of additional random biopsies and the correlation between PCa and mp-MRI parameters